Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
Ralf Ludwig, Director of the Lübeck Institute of Experimental Dermatology at the University of Lübeck, shared a post on LinkedIn:
”New Research Topic at Frontiers in Immunology – and we want your best RWD and immunology work.
‘Real-world advances in inflammatory diseases: from population data to immunological mechanisms and clinical impact’
The premise: Population-scale data is most powerful when paired with mechanistic insight.
We’re looking for studies that do both – whether that’s comparative effectiveness of biologics, immune biomarkers at scale, comorbidity mapping, or methods work on causal inference in observational cohorts.
TriNetX, UK Biobank, NHIRD, Clalit, national registries – all welcome.
Editors: Shuo-Yan Gau (Charité), Ralf Ludwig (Lübeck), Uazman Alam (Liverpool), Philip Curman (Karolinska).
Deadline for submission – 4 December 2026.”
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 17:15Giacomo Rossi: Genetic Study Reveals 10 Genes in Hyperemesis Gravidarum
-
Apr 22, 2026, 17:06Maura Boerio: Quantifying Barriers to Care in Vascular Ehlers-Danlos Syndrome
-
Apr 22, 2026, 17:05Kausik Ray։ Metabolically Healthy Obesity Is Being Re-Evaluated as a High-Risk Condition Needing Closer Attention
-
Apr 22, 2026, 16:58Baba-Jallah Epega: Sickle Cell Resilience Through Patient Voices and Clinical Insight
-
Apr 22, 2026, 16:44Francisco Chacón-Lozsán: Cytokine Storm Is Not Just Inflammation, It Is Organ Failure in Motion
-
Apr 22, 2026, 16:29CBTH 2026 Opens with First Workshop in Germany – European Hematology Association
-
Apr 22, 2026, 16:16Christopher Pittman: Superficial Venous Disease Needs Arterial-Level Follow-Up
-
Apr 22, 2026, 15:47Mohammed Alo: Being Fit Does Not Protect You from High LDL
-
Apr 22, 2026, 15:28ASH Committee Brings the Voice of Hematology to Capitol Hill